NIH awards OHSU scientists, collaborators $8.4 million to develop a cure for HIV
Only a handful of people in history have been cured of the virus; three have agreed to kick off landmark research project led by OHSU.
Research
More Research Stories
- Latest Stories
Less invasive ventilation use grows dramatically, without needed data
October 19, 2020
Researchers recommend clinical trials to assess noninvasive ventilation for cancer, dementia patients near end of life.
OHSU structural biologist elected to prestigious National Academy of Medicine
October 19, 2020
Eric Gouaux earns one of the highest honors in the fields of health, medicine.
Phil and Penny Knight receive philanthropic award from the Association of American Cancer Institutes
October 14, 2020
OHSU’s Dr. Brian Druker: ‘The Knights’ incredible generosity leaves an indelible legacy in the world of cancer research.’
Hepatitis B cure sought with help of animal research
October 13, 2020
OHSU has created nonhuman primate model for virus that has infected 2 billion worldwide.
OHSU investigating lab-made antibodies to treat COVID-19 in clinical trial
October 12, 2020
Hospitalized patients with mild to moderate coronavirus infection can volunteer.
OHSU expands COVID-19 testing lab, processes 100,000th test
October 01, 2020
With capacity for 3,000 tests a day, new lab is the most robust in the Portland-metro area.
Alcoholism research at OHSU advances with new $2.4 million federal grant
October 01, 2020
Oregon National Primate Research Center also will use grant to study impact of alcohol on COVID-19.
NIH selects OHSU to coordinate national neuroscience research involving marmosets
September 24, 2020
Oregon National Primate Research Center has strong track record in genetic analysis, data sharing.
OHSU-VA research suggests strategies to reduce missed appointments
September 17, 2020
Patients who miss visits are at a higher risk of negative health outcomes; no-shows increase health care system costs.
OHSU Doernbecher patient first human to receive trial therapy for rare, devastating form of epilepsy
September 09, 2020
Multi-site phase 1/2a clinical study works to assess safety, dosage of promising drug to treat Dravet syndrome.